Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fa Liu

Showing results (371-380 of 438) with videos related to

Pageof 44
Sort By:
Zhonghua Yi Xue Za Zhi|January 15, 2014
[Treatment efficacy of imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in chronic phase]Guan-lun Gao, Na Xu, Xuan Zhou, et al.
Phytochemistry|March 9, 2023
Isoquinoline alkaloids from Corydalis edulis Maxim. Exhibiting insulinotropic actionZhi-Tian Peng, Hui-Xia Huo, Ling-Hui Chao, et al.
Bioorganic Chemistry|June 10, 2022
Synthesis and bioactivity evaluation of novel nuciferine derivatives with antihyperuricemia and nephroprotective effectsYu-Kai Zhang, Jia-Shu Chen, Min-Min Wang, et al.
Bioorganic Chemistry|February 18, 2021
Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivativesXiu-Zheng Gao, Xu-Tao Lv, Rui-Rui Zhang, et al.
Clinical Transplantation|April 21, 2012
Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center studyYu Wang, Dai-Hong Liu, Zhi-Ping Fan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 10, 2017
Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute LeukemiaChen-Hua Yan, Qi-Fa Liu, De-Pei Wu, et al.
Blood Cells, Molecules & Diseases|January 8, 2011
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesisXiao-dan Luo, Qi-fa Liu, Yu Zhang, et al.
Blood|August 2, 2014
In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratificationYu Wang, De-Pei Wu, Qi-Fa Liu, et al.
Plos Pathogens|September 6, 2022
Escherichia coli BarA-UvrY regulates the pks island and kills Staphylococci via the genotoxin colibactin during interspecies competitionJun Jie Wong, Foo Kiong Ho, Pei Yi Choo, et al.
Disease Markers|December 15, 2015
Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Activity in Human Glioma Samples Predicts Tumor Presence and Clinical PrognosisMing-Fa Liu, Yong-Yang Hu, Tao Jin, et al.
Pageof 44

Showing results (371-380 of 438) with videos related to

Sort By:
Pageof 44
Zhonghua Yi Xue Za Zhi|January 15, 2014
[Treatment efficacy of imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in chronic phase]Guan-lun Gao, Na Xu, Xuan Zhou, et al.
Phytochemistry|March 9, 2023
Isoquinoline alkaloids from Corydalis edulis Maxim. Exhibiting insulinotropic actionZhi-Tian Peng, Hui-Xia Huo, Ling-Hui Chao, et al.
Bioorganic Chemistry|June 10, 2022
Synthesis and bioactivity evaluation of novel nuciferine derivatives with antihyperuricemia and nephroprotective effectsYu-Kai Zhang, Jia-Shu Chen, Min-Min Wang, et al.
Bioorganic Chemistry|February 18, 2021
Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivativesXiu-Zheng Gao, Xu-Tao Lv, Rui-Rui Zhang, et al.
Clinical Transplantation|April 21, 2012
Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center studyYu Wang, Dai-Hong Liu, Zhi-Ping Fan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 10, 2017
Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute LeukemiaChen-Hua Yan, Qi-Fa Liu, De-Pei Wu, et al.
Blood Cells, Molecules & Diseases|January 8, 2011
Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesisXiao-dan Luo, Qi-fa Liu, Yu Zhang, et al.
Blood|August 2, 2014
In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratificationYu Wang, De-Pei Wu, Qi-Fa Liu, et al.
Plos Pathogens|September 6, 2022
Escherichia coli BarA-UvrY regulates the pks island and kills Staphylococci via the genotoxin colibactin during interspecies competitionJun Jie Wong, Foo Kiong Ho, Pei Yi Choo, et al.
Disease Markers|December 15, 2015
Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Activity in Human Glioma Samples Predicts Tumor Presence and Clinical PrognosisMing-Fa Liu, Yong-Yang Hu, Tao Jin, et al.
Pageof 44